image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Primary Recommendations

Tristel - Sets its sights on the US market

November 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TSTL
  • Price:
  • 400p
Tristel is a manufacturer of high level sterilisation  liquids and single use wet wipes based on its proprietary chemistry and used by the NHS to sterilise medical instruments and hospital surfaces. The company’s growth has been supported by the high number of cases of hospital-acquired infections (HAIs), which come about as a direct result of surgical treatment, or from being in contact with inflected floors and mattresses. HAIs lead to an increase in the cost of hospital care, as infected patients require longer bed stays and additional treatment. In the US, the cost of this alone to the industry is estimated to be US$45bn! As the company tells me, last year there were 17m disinfection events using Tristel’s chemistry compared t ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Tristel (November 2024)
Tristel (August 2024)
Tristel - Tristel OPH approval expected by year end (April 2024)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW